Pages that link to "Q53285766"
Jump to navigation
Jump to search
The following pages link to IP-10 serum levels are not increased in mild cognitive impairment and Alzheimer's disease. (Q53285766):
Displaying 8 items.
- Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors (Q26995483) (← links)
- Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment (Q33626656) (← links)
- Cognitive Status Correlates with CXCL10/IP-10 Levels in Parkinson's Disease (Q34438204) (← links)
- Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis (Q40507310) (← links)
- Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin. (Q45972237) (← links)
- Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer's patients in a human blood brain barrier model (Q58794404) (← links)
- Current state of Alzheimer's fluid biomarkers (Q60310921) (← links)
- Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer's disease (Q92382299) (← links)